GSK461364A suppresses proliferation of gastric cancer cells and induces apoptosis
- 1 August 2023
- journal article
- research article
- Published by Elsevier BV in Toxicology in Vitro
- Vol. 90, 105610
- https://doi.org/10.1016/j.tiv.2023.105610
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Structural basis for the inhibition of Polo-like kinase 1Nature Structural & Molecular Biology, 2013
- A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancerGastric Cancer, 2011
- Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid MalignanciesClinical Cancer Research, 2011
- Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome InstabilityMolecular Cancer Therapeutics, 2010
- Cell cycle kinases as therapeutic targets for cancerNature Reviews Drug Discovery, 2009
- Prognosis of pN3 Stage Gastric CancerCancer Research and Treatment, 2009
- BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In VivoCurrent Biology, 2007
- Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenanceNature Chemical Biology, 2006
- Polo-Like Kinases: A Team in Control of the DivisionCell Cycle, 2006
- Polo-like kinases and oncogenesisOncogene, 2005